th2 Modulation CRSwNP

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG

Mepolizumab

100mg of mepolizumab every 4 weeks subcutaneously for 6 months

Trial Locations (1)

St. Paul's Sinus Centre, Vancouver

All Listed Sponsors

lead

St. Paul's Sinus Centre

OTHER